drugset / Trial / NCT01186029
Comparison of Adding EMEND to PONV/PDNV Treatment Regimen
Withdrawn
University of Nebraska
RandomizedParallel-groupDouble-blindPrevention
Summary
This study is looking at whether the addition of Aprepitant (Emend), an antiemetic, will provide added efficacy if added to 2 drugs that are already used as a standard of care for post-operative nausea and vomiting and post-discharge nausea and vomiting.
Timeline
- Start
- 2011-09-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aprepitant | Other / unclassified | 40 mg | Oral |
Indications
No indication recorded.